New BP guidelines reduce antihypertensive therapy eligibility by 6 million … – Healio | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« How stem cells can fix a broken heart with just one jab – Daily Mail

LIVE Plenary Session 2015 BioIT, April 21, 2015, 4:00 – 5:00PM – Cambridge HealthTech Institute’s 14th Annual Meeting BioIT World – Conference & Expo ’15, April 21 – 23, 2015 @Seaport World Trade Center, Boston, MA »

New BP guidelines reduce antihypertensive therapy eligibility by 6 million … – Healio

April 21, 2015 by 2012pharmaceutical

New BP guidelines reduce antihypertensive therapy eligibility by 6 million … – Healio

Reporter: Aviva Lev-Ari, PhD, RN

SAN DIEGO — The number of patients in the US who would be eligible for antihypertensive therapy decreases by 6.1 million under the guidelines written by the panel convened for the Eighth Joint National Committee, according to data presented at the…

Source: www.healio.com

See on Scoop.it – Cardiotoxicity

Posted in HTN | Leave a Comment

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Email Address

Join 1,254 other subscribers
Recent Posts
- Press Release for Five Bilingual BioMed e-Series January 29, 2023
- 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
- Verily announced other organizational changes, 1/13/2023 January 16, 2023
- Mission 4: Use of Systems Biology for Design of inhibitor of Galectins as Cancer Therapeutic – Strategy and Software December 13, 2022
- Science Has A Systemic Problem, Not an Innovation Problem December 12, 2022
- Chemistry Nobelist Carolyn Bertozzi’s years at UC Berkeley October 24, 2022
- Technion #1 in Europe in Field of AI for 2nd Straight Year October 20, 2022
- Endoglin Protein Interactome Profiling Identifies TRIM21 and Galectin-3 as New Binding Partners October 11, 2022
- The drug efflux pump MDR1 promotes intrinsic and acquired resistance to PROTACs in cancer cells October 11, 2022
- Cancer Policy Related News from Washington DC and New NCI Appointments October 4, 2022
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: